Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vismodegib and Gemcitabine in Advanced Pancreatic Cancer
NCT01195415Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jun 2010
- Primary completion
- Jul 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of vismodegib in pancreatic cancer (PC), sponsored by National Cancer Institute. Started Jun 2010; status: completed.
02
Drugs
vismodegib
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01195415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01195415.